Nature

Integrins as therapeutic targets: lessons and opportunities

Integrins are widely expressed cell-adhesion molecules with key roles in thrombosis, inflammation and cancer, and as a result are important drug targets. Inhibitors of αIIbβ3, α4 and αLβ2 integrins ...
JSTOR Daily

Primary Structure of the Leukocyte Function-Associated Molecule-1 α Subunit: An Integrin with an Embedded Domain Defining a Protein Superfamily

This is a preview. Log in through your library . The Journal of Cell Biology (JCB) is a not-for-profit publication, edited by scientists, and a leading life sciences journal. The JCB publishes papers ...
JSTOR Daily

Structure/Function Analysis of the Integrin β 1 Subunit by Epitope Mapping

The Journal of Cell Biology (JCB) is a not-for-profit publication, edited by scientists, and a leading life sciences journal. The JCB publishes papers on all aspects of cellular structure and function ...
Business Wire

Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic (“Morphic”), a biotechnology company focused on developing a new ...
Nasdaq

Morphic Presents Positive Preclinical Data Supporting MORF-057 as an Oral Inhibitor of the α4β7 Integrin and Potential Treatment for Inflammatory Bowel Disease

WALTHAM, Mass., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...
CNN

Morphic Presents Positive Preclinical Data Supporting MORF-057 as an Oral Inhibitor of the α4β7 Integrin and Potential Treatment for Inflammatory Bowel Disease

Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and ...